Cargando…
Prevention of Hepatitis B reactivation in the setting of immunosuppression
Advances in the treatment of malignant and inflammatory diseases have developed over time, with increasing use of chemotherapeutic and immunosuppressive agents of a range of drug classes with varying mechanism and potency in their effects on the immune system. These advances have been met with the c...
Autor principal: | Pattullo, Venessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946398/ https://www.ncbi.nlm.nih.gov/pubmed/27291888 http://dx.doi.org/10.3350/cmh.2016.0024 |
Ejemplares similares
-
Poor Perception of Body Weight Category amongst the Overweight and Obese with Chronic Hepatitis C: A Target for Intervention
por: Pattullo, Venessa, et al.
Publicado: (2011) -
Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases
por: Onorato, Lorenzo, et al.
Publicado: (2021) -
Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
por: Shih, Chih-An, et al.
Publicado: (2021) -
Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review
por: Tavakolpour, Soheil, et al.
Publicado: (2016) -
Roles of Hepatitis B Virus Mutations in the Viral Reactivation after Immunosuppression Therapies
por: Inoue, Jun, et al.
Publicado: (2019)